H-3A-1, Encorp Strand Garden Office,

Chimeric Antigen Receptor (CAR) T-Cell Therapy

Chimeric Antigen Receptor (CAR T-Cell) is a new form of compassionate-use cancer immunotherapy with the following benefits:

  • Enable recognition and targeting of specific cancer cells
  • Reduced side effects from treatment, as healthy cells are left undamaged
  • For late-stage cancers or when usual treatment fails

There are never any guarantees with all services and products as there are too many variables